Home Health & Hospice Data: Trends, Metrics & Margins
Navigate the shifting landscape of home health and hospice in 2025: Discover the impact of Medicare Advantage on margins and the challenges of clinician shortages.This analysis dives into the evolving market, revealing crucial trends affecting the home health primary_keyword and the hospice secondary_keyword sectors. Understand how technology adoption and strategic planning are vital for success. News Directory 3 provides key insights on the financial pressures and the innovative solutions shaping the future of care. Explore how these factors are reshaping patient care. Discover what’s next in home health and hospice.
Home Health and Hospice Face Margin Pressures, Market Shifts
updated July 02, 2025
Home health and hospice providers are grappling with notable shifts in payer mix, workforce shortages, and increasing regulatory complexity, according to experts at the Home Health Care News Capital + Strategy Conference. Medicare Advantage (MA) has become the dominant payer, creating both opportunities and challenges for agencies.
Luke Rutledge,president of Homecare Homebase,noted that his company’s data,reflecting about 45% of the market,reveals critical trends. “Medicare Advantage has now become the primary payer in the industry,” Rutledge said. “Ten years ago, I wouldn’t have believed that would happen, but here we are.”
This shift towards MA is coupled with an aging population and a projected shortage of 200,000 to 250,000 clinicians by 2031 or 2032. Nick Seabrook,managing principal at SimiTree,emphasized the financial pressures. “The cost of living and inflation are far outpacing revenue per patient per day,” Seabrook said. “Revenue is up about 17% over 10 years, but inflation is up 33%. That’s why margins are being compressed.”
Data indicates that MA patients are showing approximately -11% margins, while customary Medicare hovers around +2.3% to 2.5%. This disparity is prompting some agencies to drop certain payers to renegotiate rates, highlighting the significant gap between Medicare’s $75 per day versus MA’s $55 per day.
Access to care is also being affected, with home health admissions dropping from 75% to 63%.Lower socioeconomic zip codes are experiencing the most significant declines, possibly leading to higher-cost settings or a lack of care altogether.
clinicians are facing increased burdens with higher acuity patients and heavier caseloads. Home health caseloads have risen from 6-7 to 8 on average, and hospice caseloads from nearly 3 to 4. Consequently, home health visits per episode have decreased from 16-17 in 2018 to around 12 today.
Despite these challenges,technology offers a path forward. agencies are maintaining quality with fewer visits by leveraging remote monitoring and other technological solutions. Turnover rates are also trending down after peaking post-COVID, but remain higher than in acute care.
Seabrook highlighted the disproportionate impact on rural areas, where the percentage of total care periods dropped from 19.5% in 2021 to 17% in 2024. He stressed the importance of this data for advocating for better support from policymakers.
When asked how providers should translate these trends into strategic planning, Rutledge advised a relentless focus on clinician experience, understanding payer mix, and embracing technology. Seabrook added that negotiating with MA payers, optimizing technology ecosystems, and knowing the market are crucial steps.
Rutledge also pointed to the potential of generative AI to improve efficiency, citing Homecare Homebase’s launch of meds reconciliation via generative AI, which is expected to cut clinician time in half. He also mentioned ambient listening and scribing technologies as promising innovations.
What’s next
The home health and hospice industry must adapt to the evolving landscape by embracing technology, advocating for fair reimbursement rates, and prioritizing clinician well-being to ensure quality care for a growing patient population.